You've tried diet and exercise alone without lasting results
Read the full article in ADA Meeting News: To view or add a comment, sign in More Relevant Posts At #ADASciSessions, Klara Klein, MD, PhD, and other experts will discuss emerging trial data examining the potential benefits of GLP-1/GIP receptor agonists for people living with type 1 diabetes
Early coagonists showed improved glucose tolerance and lipid metabolism alongside weight loss driven by both reduced food intake and increased energy expenditure, such as cotadutide, a daily injectable, improves liver metabolism and has reduced HbA1c in clinical trials while also showing kidney-protective effects (e.g., reduced albumin-to-creatinine ratio)
Food companies are therefore reformulating existing products and launching new ones that fit with these changing food choices
100 Servings 100 days of daily dosing per tub
They also promote recovery from injuries and illnesses